Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma.


Journal article


G. Li Petri, S. Cascioferro, B. Parrino, G. Peters, P. Diana, E. Giovannetti
Pharmacogenomics (London), 2018

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Petri, G. L., Cascioferro, S., Parrino, B., Peters, G., Diana, P., & Giovannetti, E. (2018). Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma. Pharmacogenomics (London).


Chicago/Turabian   Click to copy
Petri, G. Li, S. Cascioferro, B. Parrino, G. Peters, P. Diana, and E. Giovannetti. “Proton-Coupled Folate Transporter as a Biomarker of Outcome to Treatment for Pleural Mesothelioma.” Pharmacogenomics (London) (2018).


MLA   Click to copy
Petri, G. Li, et al. “Proton-Coupled Folate Transporter as a Biomarker of Outcome to Treatment for Pleural Mesothelioma.” Pharmacogenomics (London), 2018.


BibTeX   Click to copy

@article{g2018a,
  title = {Proton-coupled folate transporter as a biomarker of outcome to treatment for pleural mesothelioma.},
  year = {2018},
  journal = {Pharmacogenomics (London)},
  author = {Petri, G. Li and Cascioferro, S. and Parrino, B. and Peters, G. and Diana, P. and Giovannetti, E.}
}